ModernMedicine Resource Center More Topics

Video

Sulcus-to-sulcus suture technique offers solution for silicone oil use in aphakic eyes with iris loss

Retention sutures placed sulcus-to-sulcus in the iris plane are effective for keeping the silicone oil out of the anterior chamber.

Retina Treatments

Promising results with implantable mini telescope for end-stage AMDA 5-year study of the implantable miniature telescope for bilateral, end-stage age-related macular degeneration found positive results with a few complications.
Home monitoring for AMD may have substantial impact on U.S. public healthUse of a home monitoring device to monitor patients at high risk for wet age-related macular degeneration may have a considerable public health impact over time.
Ranibizumab provides solid safety, efficacy in real-world populationTreatment with ranibizumab is safe and efficacious for currently licensed indications, according to an interim analysis of data from the LUMINOUS Study.
Patients report positive results from ocriplasmin for vitreomacular adhesionImprovement in patients’ assessment of visual function was reported after treatment with intravitreal ocriplasmin for vitreomacular adhesion.
2015 ARVO finds connections in innovative drug delivery, therapiesForward-looking research in drug delivery and therapies filled the sessions at this year’s meeting of the Association for Research in Vision and Ophthalmology.
Squalamine for AMD ‘robust’ in eyes containing CNV lesionsCombination treatment with squalamine lactate ophthalmic solution 0.2% and ranibizumab PRN resulted in improved visual function in patients with neovascular age-related macular degeneration compared with treatment with ranibizumab alone.
Trophic factor replacement targets most debilitating effects of RPDegeneration of rods in eyes with RP leads to night vision problems and loss of rod-derived cone viability factor (RdCVF) that is necessary for cone survival. Replacing RdCVF may prevent cone degeneration and loss of central vision.
Novel anti-VEGF agent may provide important advancement in AMD treatmentA novel anti-vascular endothelial growth factor agent, RTH258, produced rapid and sustained improvements in visual acuity and central subfield thickness and was non-inferior to aflibercept in a phase II trial.
Bone marrow cells show promise in degenerative, ischemic retinal diseasesThe safety and feasibility of intravitreal autologous CD34+ bone marrow cells as a potential therapy for retinal disease were evaluated in a pilot study. Preliminary findings demonstrated the treatment was feasible and researchers intend to pursue a larger, prospective study with longer follow-up.
Subretinal implant yields meaningful benefits for retinitis pigmentosaOne-year outcomes with a subretinal implant for patients blinded by retinitis pigmentosa demonstrated a marked improvement in visual capabilities.